Skip to main content

6 Result(s)

within M Peeters Remove this filter Medicine & Public Health Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Should Anti-EGFR Agents Be Used in Right-Sided RAS Wild-type Advanced Colorectal Cancer?

    Colorectal cancer is the third most common cancer worldwide with a high mortality rate at the advanced stages of the disease. Treatment options are dependent on the stage of the disease, patients’ performance ...

    Lars Triest, C. Debeuckelaere, T. Vandamme… in Current Colorectal Cancer Reports (2019)

  2. No Access

    Chapter

    Liquid Biopsy in Colorectal Cancer

    Colorectal cancer (CRC) is the third most common cancer worldwide. Oncological CRC treatment is changing gradually replacing ancient drugs with the newest targeted agents (target therapy) and immunotherapy. Th...

    A. Galvano, M. Peeters, A. B. Di Stefano, M. Castiglia… in Liquid Biopsy in Cancer Patients (2017)

  3. No Access

    Chapter

    CRC Liver Metastases

    The liver is the most common metastatic site in patients with colorectal carcinoma (CRC) [1]. Twenty-five per cent (25 %) of CRC patients have clinically detectable liver metastases at the initial diagnosis an...

    M. Peeters in Locoregional Tumor Therapy (2015)

  4. No Access

    Article

    Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel

    To assess the impact of patient-related factors, including genetic variability in genes involved in the metabolism of chemotherapeutic agents, on breast cancer-specific survival (BCSS) and recurrence-free int...

    C. Vulsteke, A. M. Pfeil, M. Schwenkglenks… in Breast Cancer Research and Treatment (2014)

  5. No Access

    Article

    Standardized added metabolic activity (SAM) IN 18F-FDG PET assessment of treatment response in colorectal liver metastases

    Standardized added metabolic activity (SAM) is a PET parameter for assessing the total metabolic load of malignant processes, avoiding partial volume effects and lesion segmentation. The potential role of this...

    Jeroen Mertens, S. De Bruyne, N. Van Damme… in European Journal of Nuclear Medicine and M… (2013)

  6. No Access

    Chapter

    Chemotherapy

    This chapter provides a synopsis of cancer chemotherapy in children. This can necessarily only be brief and further reading is recommended, since detailed knowledge of the clinical pharmacology and mechanisms ...

    D. Olive, M. Peeters in Cancer in Children (1986)